Inventor
WU SHENG-JIUN
US36 patents
⚠️ This page may combine multiple inventors who share the name “WU SHENG-JIUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN BIOTECH INC
21 patentsUS9522957B2Dec 20, 2016
Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists
JANSSEN BIOTECH INC10 citations92
US9212227B2Dec 15, 2015
ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
JANSSEN BIOTECH INC13 citations91
US9090694B2Jul 28, 2015
ST2L antibody antagonists
JANSSEN BIOTECH INC19 citations91
US9481731B2Nov 1, 2016
Toll-like receptor 3 antagonists
JANSSEN BIOTECH INC9 citations83
US8999333B2Apr 7, 2015
Human tissue factor antibody and uses thereof
JANSSEN BIOTECH INC9 citations83
US8951525B2Feb 10, 2015
Human tissue factor antibody and uses thereof
JANSSEN BIOTECH INC11 citations83
US9951137B2Apr 24, 2018
ST2L antagonists and methods of use
JANSSEN BIOTECH INC4 citations82
US9371376B2Jun 21, 2016
Anti-PHF-tau antibodies and their uses
JANSSEN BIOTECH INC10 citations80
US10894830B2Jan 19, 2021
Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses
JANSSEN BIOTECH INC7 citations78
US10450377B2Oct 22, 2019
ST2L antagonists and methods of use
JANSSEN BIOTECH INC1 citations71
US10196440B2Feb 5, 2019
Anti-PHG-tau antibodies and their uses
JANSSEN BIOTECH INC3 citations71
US10000559B2Jun 19, 2018
Anti-PHF-tau antibodies and their uses
JANSSEN BIOTECH INC2 citations71
US10844122B2Nov 24, 2020
Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof
JANSSEN BIOTECH INC4 citations68
US12065488B2Aug 20, 2024
Anti-IL-6 antibody
JANSSEN BIOTECH INC0 citations62
US11180549B2Nov 23, 2021
Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody
JANSSEN BIOTECH INC0 citations62
US9932404B2Apr 3, 2018
Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist
JANSSEN BIOTECH INC1 citations62
US9745371B2Aug 29, 2017
Anti-PHF-tau antibodies and their uses
JANSSEN BIOTECH INC1 citations60
US11866499B2Jan 9, 2024
Monospecific and multispecific anti-TMEFF2 antibodies and their uses
JANSSEN BIOTECH INC0 citations57
US12173064B2Dec 24, 2024
Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses
JANSSEN BIOTECH INC0 citations56
US9631016B2Apr 25, 2017
Pen-injector device containing anti-IL-6 antibodies
JANSSEN BIOTECH INC0 citations51
US9340613B2May 17, 2016
Anti-IL-6 antibodies, compositions, methods and uses
JANSSEN BIOTECH INC0 citations51
CUNNINGHAM MARK
5 patentsUS9255153B2Feb 9, 2016
Polynucleotides encoding Toll-Like Receptor 3 antagonists
CUNNINGHAM MARK10 citations91
US9238693B2Jan 19, 2016
Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies
CUNNINGHAM MARK3 citations82
US8540986B2Sep 24, 2013
Toll-like receptor 3 antagonists
CUNNINGHAM MARK2 citations61
US8460659B2Jun 11, 2013
Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases
CUNNINGHAM MARK2 citations61
US8409567B2Apr 2, 2013
Toll-like receptor 3 antagonists
CUNNINGHAM MARK2 citations61
CHEN YAN
4 patentsUS8226611B2Jul 24, 2012
Anti-IL-6 antibodies, compositions, methods and uses
CHEN YAN64 citations98
US8623362B2Jan 7, 2014
Anti-IL-6 antibodies
CHEN YAN44 citations97
US8067003B2Nov 29, 2011
Methods of treating conditions using anti-IL-6 antibodies
CHEN YAN46 citations97
US7833755B2Nov 16, 2010
Anti-IL-6 antibody nucleic acid molecules and methods
CHEN YAN50 citations97